News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ALS Therapy Development Institute Signs Manufacturing Agreement with ALS Therapy Development Institute for High Quality Adenoviral Production



10/17/2007 1:39:01 PM

CAMBRIDGE, Mass., Oct. 16 /PRNewswire-USNewswire/ -- The ALS Therapy Development Institute (ALS TDI) today announced it has signed an agreement with Microbix Biosystems Inc. of Toronto, Canada for the manufacturing of high quality adenoviral stocks to be tested in the mouse mode of Amyotrophic Lateral Sclerosis (ALS).

Read at PR Newswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES